CREDIT ARRANGEMENTS

12 Months Ended

Aug. 31, 2019

NOTE 10. CREDIT ARRANGEMENTS

Long-term debt was as follows:



	Weighted Average Interest Rate as of August 31, 2019	Year Ended August 31,
(in thousands)	Weighted Average Interest Rate as of August 31, 2019	2019		2018
2027 Notes	5.375%	$	300,000	$	300,000
2026 Notes	5.750%	350,000		350,000
2023 Notes	4.875%	330,000		330,000
Term Loan	4.111%	210,125		142,500
Short-term borrowings	*	3,929		—
Other, including equipment notes		60,867		47,629
Total debt		1,254,921		1,170,129
Less debt issuance costs		10,268		11,764
Total amounts outstanding		1,244,653		1,158,365
Less current maturities		13,510		19,746
Less short-term borrowings		3,929		—
Current maturities of long-term debt and short-term borrowings		17,439		19,746
Long-term debt		$	1,227,214	$	1,138,619

_________________

* As of August 31, 2019, the weighted average interest rates associated with the U.S. Program and Poland Program were 3.461% and 2.410%, respectively.

In July 2017, the Company issued $300.0 million of 5.375% Senior Notes due July 2027 (the "2027 Notes"). Interest on these notes is payable semiannually.

In May 2018, the Company issued $350.0 million of 5.75% Senior Notes due April 2026 (the "2026 Notes"). Issuance costs associated with the 2026 Notes were approximately $5.3 million. Interest on the 2026 Notes is payable semiannually.

In May 2013, the Company issued $330.0 million of 4.875% Senior Notes due May 2023 (the "2023 Notes"). Interest on these notes is payable semiannually.

The Company has a $350.0 million revolving credit facility (the "Revolver") pursuant to the Fourth Amended and Restated Credit Agreement (as amended, the "Credit Agreement") and a term loan contemplated thereunder (the "Term Loan"). The Term Loan was funded in two tranches: one drawn on July 13, 2017 with an original principal amount of $150.0 million, and one drawn on November 1, 2018 with an original principal amount of $180.0 million. The Credit Agreement and the Term Loan are coterminous with a maturity date in June 2022. The Company was required to make quarterly payments on the Term Loan equal to 1.25% of the original principal amount. However, principal prepayments in 2019 have satisfied all contractually obligated quarterly principal payments through the maturity of the Term Loan. The maximum availability under the Revolver can be increased to $600.0 million with bank approval. The Company's obligations under the Credit Agreement are collateralized by its U.S. inventory and U.S. fabrication receivables. The Credit Agreement's capacity includes a $50.0 million sub-limit for the issuance of stand-by letters of credit.

The Company had no amounts drawn under the Revolver at August 31, 2019 or 2018. The availability under the Revolver was reduced by outstanding stand-by letters of credit of $3.0 million and $3.3 million at August 31, 2019 and 2018, respectively.

Under the Credit Agreement, the Company is required to comply with certain financial and non-financial covenants, including covenants to maintain: (i) an interest coverage ratio (consolidated EBITDA to consolidated interest expense, as each is defined in the Credit Agreement) of not less than 2.50 to 1.00 and (ii) a debt to capitalization ratio (consolidated funded debt to total capitalization, as each is defined in the Credit Agreement) that does not exceed 0.60 to 1.00. Loans under the Credit Agreement bear interest based on the Eurocurrency rate, a base rate, or the LIBOR rate. At August 31, 2019, the Company's interest coverage ratio was 5.93 to 1.00 and the Company's debt to capitalization ratio was 0.44 to 1.00.

The Company also has credit facilities in Poland, through its subsidiary, CMC Poland Sp. z.o.o. ("CMCP"), available to support working capital, short-term cash needs, letters of credit, financial assurance and other trade finance-related matters. At August 31, 2019 and 2018, CMCP's credit facilities totaled Polish zloty ("PLN") 275.0 million, or $69.0 million, and PLN 225.0 million, or $60.8 million, respectively. These facilities expire in March 2022. At August 31, 2019 and 2018, no amounts were outstanding under these facilities. The available balance of these credit facilities was reduced by outstanding stand-by letters of credit, guarantees and/or other financial assurance instruments, which totaled $1.1 million at August 31, 2019 and August 31, 2018. During 2019, 2018 and 2017, CMCP had no borrowings or repayments under its credit facilities.

At August 31, 2019, the Company was in compliance with all of the covenants contained in its credit arrangements.

The scheduled maturities of the Company's long-term debt are as follows:



Year Ended August 31,	(in thousands)
2020	$	17,439
2021	10,827
2022	219,049
2023	337,264
2024	7,717
Thereafter	662,625
Total long-term debt	1,254,921
Less debt issuance costs	10,268
Total long-term debt outstanding	$	1,244,653

The Company capitalized $0.3 million, $7.3 million and $9.8 million of interest in the cost of property, plant and equipment during 2019, 2018 and 2017, respectively.

Accounts Receivable Programs

CMC has a $200.0 million U.S. trade accounts receivable program (the "U.S. Program"), which expires in August 2020. Under the U.S. Program, CMC contributes, and certain of its subsidiaries transfer without recourse, certain eligible trade accounts receivable to CMC Receivables, Inc. ("CMCRV"), a wholly-owned subsidiary of CMC. CMCRV is structured to be a bankruptcy-remote entity formed for the sole purpose of facilitating transfers of trade accounts receivable generated by the Company. CMCRV transfers the trade accounts receivable in their entirety to two financial institutions. Under the U.S. Program, with the consent of both CMCRV and the program's administrative agent, the amount advanced by the financial institutions can be increased to a maximum of $300.0 million for all trade accounts receivable. The remaining portion of the purchase price of the trade accounts receivable takes the form of subordinated notes from the respective financial institutions. These notes will be satisfied from the ultimate collection of the trade accounts receivable after payment of certain fees and other costs. The U.S. Program contains certain cross-default provisions whereby a termination event could occur if the Company defaulted under certain of its credit arrangements. The covenants contained in the receivables purchase agreement are consistent with the Credit Agreement. Advances taken under the U.S. Program incur interest based on LIBOR plus a margin. The Company had no advance payments outstanding under the U.S. Program at August 31, 2019.

In addition to the U.S. Program, the Company's international subsidiary in Poland transfers trade accounts receivable to financial institutions without recourse (the "Poland Program"). The Poland Program has a facility limit of PLN 220.0 million ($55.2 million as of August 31, 2019) and allows the Company's Polish subsidiaries to obtain an advance of up to 90% of eligible trade accounts receivable transferred under the terms of the arrangement. Advances taken under the Poland Program incur interest based on the Warsaw Interbank Offered Rate ("WIBOR") plus a margin. The Company had advance payments outstanding of $3.9 million under the Poland Program at August 31, 2019.

Prior to 2019, the Company accounted for transfers of trade accounts receivable as sales, and the trade accounts receivable balances transferred were removed from the consolidated balance sheets. On September 1, 2018, the Company amended certain terms of both the U.S. and Poland Programs, disqualifying the accounting of the transfer of such receivables as sales. As a result of the amendments, beginning in 2019, any advances outstanding under the U.S. and Poland Programs are recorded as debt on the Company's consolidated balance sheets.